Back

Impact of sarcopenia and dynapenia on the prognosis of right heart failure

17 May 2025 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes Comorbidities HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Carlos Patricio Chavez Guzman

Mexico City (Mexico)

6 More presentations in this session

Presentation thumbnail
Frailty and bleeding events in patients with heart failure: Insights from the JROADHF-NEXT
Doctor T. Nakade (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
The role of cystatin c-creatinine eGFR difference in assessing renal function and its correlation with frailty in patients with worsening heart failure: a real-world study
Doctor C. Fumagalli (Varese, IT)
Abstract Slides Video
Presentation thumbnail
Specific antidepressant effects among heart failure patients with depression: real life data
Professor M. Yilmaz (Izmir, TR)
Abstract Slides Video
Presentation thumbnail
The reverse cardio-oncology perspective: the incidence of, and mortality from, cancer subsequent to a diagnosis of heart failure; an updated review and meta-analysis of observational studies.
Doctor L. Sanasi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Prevalence of diagnosed heart failure in 12 million patients with type 2 diabetes mellitus: a systematic review and meta-analysis
Mr U. Razzaq (Glasgow, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Interplay of frailty, sarcopenia, depression, and cardio-oncology in heart failure outcomes

The Event

Event poster

Heart Failure 2025

17 May - 20 May 2025
You may be interested in
thumbnail
Congress Presentation
Impact of sarcopenia and dynapenia on the prognosis of patients at high risk of pulmonary hypertension
thumbnail
Congress Presentation
Echocardiographic parameters in patients with right heart failure and sarcopenia.
thumbnail
Congress Presentation
Dynapenia, sarcopenia, hydric alterations and body composition according to the type of heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources